Atrial Fibrillation
Monday, August 20th, 2012
Heartrhythmjournal.com: July 5, 2012 Idiopathic atrial fibrillation (AF) refers to a clinically lacking cardiovascular or pulmonary disease generating the pathophysiological substrate for the arrhythmia. However, since idiopathic AF is associated with an increased event rate, it could be a harbinger of as yet undetected underlying heart disease. We studied the prevalence of coronary artery disease (CAD) […]
Atrial Fibrillation
Monday, August 20th, 2012
Recent Insights Into the Role of the Autonomic Nervous System in the Creation of Substrate for Atrial Fibrillation Implications for Therapies Targeting the Atrial Autonomic Nervous System In this review, we discuss recent developments in our understanding of the role of the autonomic nervous system in creating atrial fibrillation (AF) substrate and on how these […]
Atrial Fibrillation, Guidelines
Monday, August 20th, 2012
Expert Consensus Statement Recommends Process for Assessing Stroke and Bleeding Risk for Appropriate Anticoagulant Use Clotcare.com: 7/19/12 WASHINGTON, DC (July 19, 2012) – The Alliance for Aging Research (Alliance) announced the release of a new consensus statementwritten by leading experts in the area of stroke prevention in atrial fibrillation (A Fib). The consensus development was spearheaded by the Atrial […]
Atrial Fibrillation
Friday, August 10th, 2012
American College of Cardiology Foundation: August 7, 2012 Since the seminal paper by Haissaguerre et al. (1) describing the importance of pulmonary vein (PV) triggers in the initiation of paroxysmal atrial fibrillation (AF), PV isolation has become the cornerstone of catheter ablation for AF, demonstrating acceptable results (2). By contrast, reported long-term success rates after catheter […]
Atrial Fibrillation
Friday, August 10th, 2012
American Heart Association: August 7, 2012 Background and Purpose—Atrial fibrillation (AF) is an independent risk factor for stroke. Recent studies have demonstrated that the CHA2DS2-VASc scheme is useful for selecting patients who are truly at low risk. The goal of the present study was to compare the risk of ischemic stroke among AF patients with a […]
Atrial Fibrillation
Friday, August 10th, 2012
American Heart Association: August 6, 2012 Background—Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation (AF) presenting with myocardial infarction (MI) and/or undergoing coronary intervention (PCI). We investigated the risk and time-frame for bleeding following MI/PCI in AF patients according to antithrombotic treatment. Methods and Results—Patients with AF and admitted with MI or for […]
Atrial Fibrillation
Friday, August 10th, 2012
American Heart Association: Thursday, Aug. 2, 2012 Atrial fibrillation (AF) is an important cause of stroke and the likely cause of ischemic stroke in 20% of men and 30% of women.1 Cardiac embolism is more likely to result in a major cerebral vessel occlusion, hence the strokes associated with AF more commonly result in severe disability or […]
Atrial Fibrillation
Friday, August 10th, 2012
Nature Reviews Nephrology (24 July 2012) Atrial fibrillation is an important cause of preventable, disabling stroke and is particularly frequent in patients with chronic kidney disease (CKD). Stage 3 CKD is an independent risk factor for stroke in patients with atrial fibrillation. Warfarin anticoagulation is efficacious for stroke prevention in atrial fibrillation patients with stage 3 […]
Atrial Fibrillation
Tuesday, August 7th, 2012
Stopafib.org: By Mellanie True Hills August 2, 2012 Summary: Dr. James Reiffel discusses the treatment of atrial fibrillation with medications, including rate control vs. rhythm control, new drug combinations, and research into new afib drugs. Reading and watching time is approximately 10 minutes In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new […]
Atrial Fibrillation
Tuesday, August 7th, 2012
Content.onlinejacc.org: 8/1/12 The objective of this study was to compare the predictive performance of bleeding risk–estimation tools in a cohort of patients with atrial fibrillation (AF) undergoing anticoagulation. Background Three bleeding risk–prediction schemes have been derived for and validated in patients with AF: HEMORR2HAGES (Hepatic or Renal Disease, Ethanol Abuse, Malignancy, Older Age, Reduced Platelet Count or […]
